The store will not work correctly when cookies are disabled.
6-Amino-1'-methyl-5-(1-(p-tolyl)ethoxy)[3,4'-bipyridin]-2'(1'H)-one
ID: ALA4518690
PubChem CID: 155541627
Max Phase: Preclinical
Molecular Formula: C20H21N3O2
Molecular Weight: 335.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(C(C)Oc2cc(-c3ccn(C)c(=O)c3)cnc2N)cc1
Standard InChI: InChI=1S/C20H21N3O2/c1-13-4-6-15(7-5-13)14(2)25-18-10-17(12-22-20(18)21)16-8-9-23(3)19(24)11-16/h4-12,14H,1-3H3,(H2,21,22)
Standard InChI Key: MGGOWLLXUKUFKF-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
41.0492 -4.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0481 -4.9525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7629 -5.3653 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.4793 -4.9519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4765 -4.1214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7610 -3.7123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3354 -3.7083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3371 -2.8823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6267 -2.4700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9099 -2.8792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.9081 -3.7052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6232 -4.1220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1944 -5.3633 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.6296 -1.6451 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.1894 -3.7062 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.1863 -2.8812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8992 -2.4660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4703 -2.4713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6105 -2.8794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.3229 -2.4649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.3203 -1.6389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.5992 -1.2294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8897 -1.6462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.0326 -1.2228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1968 -2.4642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
1 7 1 0
4 13 1 0
9 14 2 0
5 15 1 0
15 16 1 0
16 17 1 0
16 18 1 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
21 24 1 0
10 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 335.41 | Molecular Weight (Monoisotopic): 335.1634 | AlogP: 3.48 | #Rotatable Bonds: 4 |
Polar Surface Area: 70.14 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.97 | CX LogP: 2.80 | CX LogD: 2.79 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.79 | Np Likeness Score: -0.71 |
References
1. Chen W, Guo X, Zhang C, Ke D, Zhang G, Yu Y.. (2019) Discovery of 2-aminopyridines bearing a pyridone moiety as potent ALK inhibitors to overcome the crizotinib-resistant mutants., 183 [PMID:31569004] [10.1016/j.ejmech.2019.111734] |